303 related articles for article (PubMed ID: 24392683)
1. Additional local therapy with primary re-excision or radiation therapy improves survival and local control after incomplete or close surgical excision of mast cell tumors in dogs.
Kry KL; Boston SE
Vet Surg; 2014 Feb; 43(2):182-9. PubMed ID: 24392683
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004).
Bacon NJ; Dernell WS; Ehrhart N; Powers BE; Withrow SJ
J Am Vet Med Assoc; 2007 Feb; 230(4):548-54. PubMed ID: 17302554
[TBL] [Abstract][Full Text] [Related]
3. Recurrence rate, clinical outcome, and cellular proliferation indices as prognostic indicators after incomplete surgical excision of cutaneous grade II mast cell tumors: 28 dogs (1994-2002).
Séguin B; Besancon MF; McCallan JL; Dewe LL; Tenwolde MC; Wong EK; Kent MS
J Vet Intern Med; 2006; 20(4):933-40. PubMed ID: 16955819
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008-2012).
Pratschke KM; Atherton MJ; Sillito JA; Lamm CG
J Am Vet Med Assoc; 2013 Nov; 243(10):1436-41. PubMed ID: 24171373
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy for incompletely excised grade II canine mast cell tumors.
Poirier VJ; Adams WM; Forrest LJ; Green EM; Dubielzig RR; Vail DM
J Am Anim Hosp Assoc; 2006; 42(6):430-4. PubMed ID: 17088389
[TBL] [Abstract][Full Text] [Related]
7. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision.
Weisse C; Shofer FS; Sorenmo K
J Am Anim Hosp Assoc; 2002; 38(1):71-3. PubMed ID: 11804319
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
9. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G
J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of dogs undergoing surgical resection of mast cell tumors and soft tissue sarcomas: A prospective 2-year-long study.
Milovancev M; Townsend KL; Tuohy JL; Gorman E; Bracha S; Curran KM; Russell DS
Vet Surg; 2020 Jan; 49(1):96-105. PubMed ID: 31044443
[TBL] [Abstract][Full Text] [Related]
11. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs.
Schultheiss PC; Gardiner DW; Rao S; Olea-Popelka F; Tuohy JL
J Am Vet Med Assoc; 2011 Jun; 238(11):1464-9. PubMed ID: 21627510
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999).
Séguin B; Leibman NF; Bregazzi VS; Ogilvie GK; Powers BE; Dernell WS; Fettman MJ; Withrow SJ
J Am Vet Med Assoc; 2001 Apr; 218(7):1120-3. PubMed ID: 11318363
[TBL] [Abstract][Full Text] [Related]
13. Results of surgical excision and evaluation of factors associated with survival time in dogs with lingual neoplasia: 97 cases (1995-2008).
Culp WT; Ehrhart N; Withrow SJ; Rebhun RB; Boston S; Buracco P; Reiter AM; Schallberger SP; Aldridge CF; Kent MS; Mayhew PD; Brown DC
J Am Vet Med Assoc; 2013 May; 242(10):1392-7. PubMed ID: 23634684
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of scar revision after inadequate primary excision of cutaneous mast cell tumors in 85 dogs (2000-2013).
Karbe GT; Davis E; Runge JJ; Brown DC; Holt DE
Vet Surg; 2021 May; 50(4):807-815. PubMed ID: 33666268
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of histological grade and histologically tumour-free margins as predictors of local recurrence in completely excised canine mast cell tumours.
Donnelly L; Mullin C; Balko J; Goldschmidt M; Krick E; Hume C; Brown DC; Sorenmo K
Vet Comp Oncol; 2015 Mar; 13(1):70-6. PubMed ID: 23451809
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004-2008).
Schwab TM; Popovitch C; DeBiasio J; Goldschmidt M
J Am Anim Hosp Assoc; 2014; 50(3):187-91. PubMed ID: 24659731
[TBL] [Abstract][Full Text] [Related]
17. Intercalary bone grafts for joint and limb preservation in 17 dogs with high-grade malignant tumors of the diaphysis.
Liptak JM; Dernell WS; Straw RC; Jameson VJ; Lafferty MH; Rizzo SA; Withrow SJ
Vet Surg; 2004; 33(5):457-67. PubMed ID: 15362984
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998).
Hahn KA; King GK; Carreras JK
J Am Vet Med Assoc; 2004 Jan; 224(1):79-82. PubMed ID: 14710881
[TBL] [Abstract][Full Text] [Related]
19. Outcomes following surgical excision or surgical excision combined with adjunctive, hypofractionated radiotherapy in dogs with oral squamous cell carcinoma or fibrosarcoma.
Riggs J; Adams VJ; Hermer JV; Dobson JM; Murphy S; Ladlow JF
J Am Vet Med Assoc; 2018 Jul; 253(1):73-83. PubMed ID: 29911943
[TBL] [Abstract][Full Text] [Related]
20. Canine subcutaneous mast cell tumor: characterization and prognostic indices.
Thompson JJ; Pearl DL; Yager JA; Best SJ; Coomber BL; Foster RA
Vet Pathol; 2011 Jan; 48(1):156-68. PubMed ID: 21078881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
